320 related articles for article (PubMed ID: 17507621)
1. The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer--a potential tool for breast cancer risk assessment and biomarker evaluation.
Visvanathan K; Santor D; Ali SZ; Brewster A; Arnold A; Armstrong DK; Davidson NE; Helzlsouer KJ
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):950-5. PubMed ID: 17507621
[TBL] [Abstract][Full Text] [Related]
2. Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer.
Higgins SA; Matloff ET; Rimm DL; Dziura J; Haffty BG; King BL
Breast Cancer Res; 2005; 7(6):R1017-22. PubMed ID: 16280052
[TBL] [Abstract][Full Text] [Related]
3. Patient variables that predict atypical cytology by nipple duct lavage.
Bushnaq ZI; Ashfaq R; Leitch AM; Euhus D
Cancer; 2007 Apr; 109(7):1247-54. PubMed ID: 17326050
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer.
Zalles CM; Kimler BF; Simonsen M; Clark JL; Metheny T; Fabian CJ
Breast Cancer Res Treat; 2006 May; 97(2):191-7. PubMed ID: 16322885
[TBL] [Abstract][Full Text] [Related]
5. Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation.
Mitchell G; Antill YC; Murray W; Kirk J; Salisbury E; Lindeman GJ; Di Iulio J; Milner AD; Devereaux L; Phillips KA
Breast Cancer Res; 2005; 7(6):R1122-31. PubMed ID: 16457692
[TBL] [Abstract][Full Text] [Related]
6. Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer risk.
Kurian AW; Mills MA; Jaffee M; Sigal BM; Chun NM; Kingham KE; Collins LC; Nowels KW; Plevritis SK; Garber JE; Ford JM; Hartman AR
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1082-9. PubMed ID: 15894656
[TBL] [Abstract][Full Text] [Related]
7. Coming soon to your lab: NAF for breast-cancer risk assessment.
Bentz J
MLO Med Lab Obs; 2008 Oct; 40(10):52-3. PubMed ID: 18988557
[No Abstract] [Full Text] [Related]
8. Technical enhancements to breast ductal lavage.
Tondre J; Nejad M; Casano A; Mills D; Love S
Ann Surg Oncol; 2008 Oct; 15(10):2734-8. PubMed ID: 18636293
[TBL] [Abstract][Full Text] [Related]
9. Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population.
Tice JA; Miike R; Adduci K; Petrakis NL; King E; Wrensch MR
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):324-8. PubMed ID: 15734953
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of breast duct lavage performed by a physician extender.
Redlich PN; Purdy AC; Shidham VB; Yun HJ; Walker A; Ota D
Surgery; 2004 Nov; 136(5):1077-80; discussion 1080-2. PubMed ID: 15523404
[TBL] [Abstract][Full Text] [Related]
11. Ductal lavage findings in women with known breast cancer undergoing mastectomy.
Khan SA; Wiley EL; Rodriguez N; Baird C; Ramakrishnan R; Nayar R; Bryk M; Bethke KB; Staradub VL; Wolfman J; Rademaker A; Ljung BM; Morrow M
J Natl Cancer Inst; 2004 Oct; 96(20):1510-7. PubMed ID: 15494601
[TBL] [Abstract][Full Text] [Related]
12. Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: a 25-year prospective study.
Buehring GC; Letscher A; McGirr KM; Khandhar S; Che LH; Nguyen CT; Hackett AJ
Breast Cancer Res Treat; 2006 Jul; 98(1):63-70. PubMed ID: 16685591
[TBL] [Abstract][Full Text] [Related]
13. Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk women.
Patil DB; Lankes HA; Nayar R; Masood S; Bryk M; Hou N; Rademaker A; Khan SA
Breast Cancer Res Treat; 2008 Nov; 112(2):327-33. PubMed ID: 18097749
[TBL] [Abstract][Full Text] [Related]
14. Patient and duct selection for nipple duct lavage.
Maddux AJ; Ashfaq R; Naftalis E; Leitch AM; Hoover S; Euhus D
Am J Surg; 2004 Oct; 188(4):390-4. PubMed ID: 15474432
[TBL] [Abstract][Full Text] [Related]
15. Nipple aspirate fluid cytology in breast carcinoma.
Krishnamurthy S; Sneige N; Thompson PA; Marcy SM; Singletary SE; Cristofanilli M; Hunt KK; Kuerer HM
Cancer; 2003 Apr; 99(2):97-104. PubMed ID: 12704689
[TBL] [Abstract][Full Text] [Related]
16. Cytomorphology as a risk predictor: experience with fine needle aspiration biopsy, nipple fluid aspiration, and ductal lavage.
Masood S
Clin Lab Med; 2005 Dec; 25(4):827-43, viii-ix. PubMed ID: 16308095
[TBL] [Abstract][Full Text] [Related]
17. Atypia and Ki-67 expression from ductal lavage in women at different risk for breast cancer.
Cazzaniga M; Severi G; Casadio C; Chiapparini L; Veronesi U; Decensi A
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1311-5. PubMed ID: 16835329
[TBL] [Abstract][Full Text] [Related]
18. Reproducibility of cytologic atypia in repeat nipple duct lavage.
Johnson-Maddux A; Ashfaq R; Cler L; Naftalis E; Leitch AM; Hoover S; Euhus DM
Cancer; 2005 Mar; 103(6):1129-36. PubMed ID: 15685620
[TBL] [Abstract][Full Text] [Related]
19. Endocrine biomarkers in ductal lavage samples from women at high risk for breast cancer.
Bhandare D; Nayar R; Bryk M; Hou N; Cohn R; Golewale N; Parker NP; Chatterton RT; Rademaker A; Khan SA
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2620-7. PubMed ID: 16284387
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib decreases prostaglandin E2 concentrations in nipple aspirate fluid from high risk postmenopausal women and women with breast cancer.
Sauter ER; Qin W; Schlatter L; Hewett JE; Flynn JT
BMC Cancer; 2006 Oct; 6():248. PubMed ID: 17049084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
